Craig Bijou

Stock Analyst at B of A Securities

(3.85)
# 576
Out of 4,832 analysts
62
Total ratings
64.71%
Success rate
61.54%
Average return

Stocks Rated by Craig Bijou

PROCEPT BioRobotics
Apr 25, 2025
Maintains: Buy
Price Target: $104$84
Current: $53.04
Upside: +58.37%
RxSight
Mar 21, 2025
Maintains: Buy
Price Target: $60$36
Current: $13.20
Upside: +172.73%
Teleflex
Mar 4, 2025
Downgrades: Underperform
Price Target: $235$140
Current: $126.80
Upside: +10.41%
Bausch + Lomb
Feb 20, 2025
Maintains: Underperform
Price Target: $18$17
Current: $11.76
Upside: +44.56%
Globus Medical
Jan 9, 2025
Upgrades: Neutral
Price Target: $80$97
Current: $58.25
Upside: +66.52%
Integra LifeSciences Holdings
Oct 7, 2024
Maintains: Underperform
Price Target: $26$18
Current: $13.51
Upside: +33.23%
Integer Holdings
Oct 1, 2024
Maintains: Buy
Price Target: $135$145
Current: $121.00
Upside: +19.83%
Merit Medical Systems
Sep 16, 2024
Maintains: Neutral
Price Target: $92$103
Current: $97.61
Upside: +5.52%
Haemonetics
Sep 11, 2024
Initiates: Neutral
Price Target: $85
Current: $69.14
Upside: +22.94%
GE HealthCare Technologies
May 1, 2024
Maintains: Neutral
Price Target: $94$86
Current: $73.83
Upside: +16.48%
Initiates: Buy
Price Target: $95
Current: $81.76
Upside: +16.19%
Maintains: Buy
Price Target: $43$36
Current: $18.59
Upside: +93.65%
Reiterates: Overweight
Price Target: $23$45
Current: $6.19
Upside: +626.98%
Maintains: Overweight
Price Target: $1$8
Current: $0.45
Upside: +1,688.11%
Maintains: Neutral
Price Target: $60$30
Current: $4.72
Upside: +535.59%
Reiterates: Overweight
Price Target: $17$13
Current: $9.81
Upside: +32.52%
Maintains: Neutral
Price Target: $48$42
Current: $12.49
Upside: +236.27%
Reiterates: Overweight
Price Target: $207$230
Current: $563.95
Upside: -59.22%
Maintains: Neutral
Price Target: $190$230
Current: $387.53
Upside: -40.65%